pharmaceuticals-and-healthcare

EMEA (Europe, Middle East and Africa) Biopharmaceuticals Market Report 2017


Published On : Apr 2017

Category : Pharmaceutical

No. of Pages : 102 pages

  • $4000
  • $8000

Please click below to avail discount on this report

In this report, the EMEA Biopharmaceuticals market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (Million MT), revenue (Million USD), market share and growth rate of Biopharmaceuticals for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biopharmaceuticals market competition by top manufacturers/players, with Biopharmaceuticals sales volume (Million MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Roche
Amgen
AbbVie
Sanofi-Aventis
Johnson & Johnson
Pfizer
Novo Nordisk
Eli Lilly
Novartis
Merck

On the basis of product, this report displays the sales volume (Million MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Monoclonal Antibodies
Interferon
Colony-Stimulating Factor
Erythropoietin
Insulin
Vaccines
Growth Hormones
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (Million MT), market share and growth rate of Biopharmaceuticals for each application, including
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

In the recent times, the global market for Emea europe middle east and africa biopharmaceuticals market report 2017 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Emea europe middle east and africa biopharmaceuticals market report 2017 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Emea europe middle east and africa biopharmaceuticals market report 2017 production processes, which is also reflecting positively on the growth of this market.

The research report on the Emea europe middle east and africa biopharmaceuticals market report 2017 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Emea europe middle east and africa biopharmaceuticals market report 2017 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Emea europe middle east and africa biopharmaceuticals market report 2017, including the definition, classification, and industry chain structure of Emea europe middle east and africa biopharmaceuticals market report 2017, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Emea europe middle east and africa biopharmaceuticals market report 2017.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Emea europe middle east and africa biopharmaceuticals market report 2017 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Emea europe middle east and africa biopharmaceuticals market report 2017, implemented in each of the geographical segments. The predominant applications of the Emea europe middle east and africa biopharmaceuticals market report 2017 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Emea europe middle east and africa biopharmaceuticals market report 2017 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Emea europe middle east and africa biopharmaceuticals market report 2017 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Product Picture of Biopharmaceuticals
Figure EMEA Biopharmaceuticals Sales Volume (Million MT) by Type (2012-2022)
Figure EMEA Biopharmaceuticals Sales Volume Market Share by Type (Product Category) in 2016
Figure Monoclonal Antibodies Product Picture
Figure Interferon Product Picture
Figure Colony-Stimulating Factor Product Picture
Figure Erythropoietin Product Picture
Figure Insulin Product Picture
Figure Vaccines Product Picture
Figure Growth Hormones Product Picture
Figure Other Product Picture
Figure EMEA Biopharmaceuticals Sales Volume (Million MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Biopharmaceuticals by Application in 2016
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure EMEA Biopharmaceuticals Market Size (Million USD) by Region (2012-2022)
Figure Europe Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biopharmaceuticals Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biopharmaceuticals Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biopharmaceuticals Market Major Players Product Sales Volume (Million MT) (2012-2017)
Table EMEA Biopharmaceuticals Sales Volume (Million MT) of Major Players (2012-2017)
Table EMEA Biopharmaceuticals Sales Share by Players (2012-2017)
Figure 2016 Biopharmaceuticals Sales Share by Players
Figure 2017 Biopharmaceuticals Sales Share by Players
Figure EMEA Biopharmaceuticals Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biopharmaceuticals Revenue (Million USD) by Players (2012-2017)
Table EMEA Biopharmaceuticals Revenue Share by Players (2012-2017)
Table 2016 EMEA Biopharmaceuticals Revenue Share by Players
Table 2017 EMEA Biopharmaceuticals Revenue Share by Players
Table EMEA Biopharmaceuticals Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Biopharmaceuticals Sales (Million MT) and Market Share by Type (2012-2017)
Table EMEA Biopharmaceuticals Sales Share by Type (2012-2017)
Figure Sales Market Share of Biopharmaceuticals by Type (2012-2017)
Figure EMEA Biopharmaceuticals Sales Market Share by Type (2012-2017)
Table EMEA Biopharmaceuticals Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biopharmaceuticals Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biopharmaceuticals by Type in 2016
Table EMEA Biopharmaceuticals Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Biopharmaceuticals Sales (Million MT) and Market Share by Application (2012-2017)
Table EMEA Biopharmaceuticals Sales Share by Application (2012-2017)
Figure Sales Market Share of Biopharmaceuticals by Application (2012-2017)
Figure EMEA Biopharmaceuticals Sales Market Share by Application in 2016
Table EMEA Biopharmaceuticals Sales (Million MT) and Market Share by Region (2012-2017)
Table EMEA Biopharmaceuticals Sales Share by Region (2012-2017)
Figure Sales Market Share of Biopharmaceuticals by Region (2012-2017)
Figure EMEA Biopharmaceuticals Sales Market Share in 2016
Table EMEA Biopharmaceuticals Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biopharmaceuticals Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biopharmaceuticals by Region (2012-2017)
Figure EMEA Biopharmaceuticals Revenue Market Share Regions in 2016
Table EMEA Biopharmaceuticals Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Europe Biopharmaceuticals Revenue and Growth Rate (2012-2017)
Table Europe Biopharmaceuticals Sales (Million MT) by Type (2012-2017)
Table Europe Biopharmaceuticals Market Share by Type (2012-2017)
Figure Europe Biopharmaceuticals Market Share by Type in 2016
Table Europe Biopharmaceuticals Sales (Million MT) by Application (2012-2017)
Table Europe Biopharmaceuticals Market Share by Application (2012-2017)
Figure Europe Biopharmaceuticals Market Share by Application in 2016
Table Europe Biopharmaceuticals Sales (Million MT) by Countries (2012-2017)
Table Europe Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Europe Biopharmaceuticals Sales Market Share by Countries in 2016
Table Europe Biopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Europe Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Europe Biopharmaceuticals Revenue Market Share by Countries in 2016
Figure Germany Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure France Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure UK Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Russia Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Italy Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Benelux Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Middle East Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Middle East Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biopharmaceuticals Sales (Million MT) by Type (2012-2017)
Table Middle East Biopharmaceuticals Market Share by Type (2012-2017)
Figure Middle East Biopharmaceuticals Market Share by Type (2012-2017)
Table Middle East Biopharmaceuticals Sales (Million MT) by Applications (2012-2017)
Table Middle East Biopharmaceuticals Market Share by Applications (2012-2017)
Figure Middle East Biopharmaceuticals Sales Market Share by Application in 2016
Table Middle East Biopharmaceuticals Sales Volume (Million MT) by Countries (2012-2017)
Table Middle East Biopharmaceuticals Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biopharmaceuticals Sales Volume Market Share by Countries in 2016
Table Middle East Biopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Middle East Biopharmaceuticals Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Israel Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure UAE Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Iran Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Africa Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Africa Biopharmaceuticals Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biopharmaceuticals Sales (Million MT) by Type (2012-2017)
Table Africa Biopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Type (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Type in 2016
Table Africa Biopharmaceuticals Sales (Million MT) by Application (2012-2017)
Table Africa Biopharmaceuticals Sales Market Share by Application (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Application (2012-2017)
Table Africa Biopharmaceuticals Sales Volume (Million MT) by Countries (2012-2017)
Table Africa Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Countries (2012-2017)
Figure Africa Biopharmaceuticals Sales Market Share by Countries in 2016
Table Africa Biopharmaceuticals Revenue (Million USD) by Countries (2012-2017)
Table Africa Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Biopharmaceuticals Revenue Market Share by Countries (2012-2017)
Figure Africa Biopharmaceuticals Revenue Market Share by Countries in 2016
Figure South Africa Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Nigeria Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Egypt Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Algeria Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Table Roche Biopharmaceuticals Basic Information List
Table Roche Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Roche Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Roche Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Amgen Biopharmaceuticals Basic Information List
Table Amgen Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Amgen Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Amgen Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table AbbVie Biopharmaceuticals Basic Information List
Table AbbVie Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AbbVie Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure AbbVie Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure AbbVie Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Sanofi-Aventis Biopharmaceuticals Basic Information List
Table Sanofi-Aventis Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi-Aventis Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Sanofi-Aventis Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Sanofi-Aventis Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Biopharmaceuticals Basic Information List
Table Johnson & Johnson Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Pfizer Biopharmaceuticals Basic Information List
Table Pfizer Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Pfizer Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Biopharmaceuticals Basic Information List
Table Novo Nordisk Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novo Nordisk Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Novo Nordisk Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Eli Lilly Biopharmaceuticals Basic Information List
Table Eli Lilly Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Eli Lilly Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Eli Lilly Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Eli Lilly Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Novartis Biopharmaceuticals Basic Information List
Table Novartis Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Novartis Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Novartis Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Merck Biopharmaceuticals Basic Information List
Table Merck Biopharmaceuticals Sales (Million MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Biopharmaceuticals Sales (Million MT) and Growth Rate (2012-2017)
Figure Merck Biopharmaceuticals Sales Market Share in EMEA (2012-2017)
Figure Merck Biopharmaceuticals Revenue Market Share in EMEA (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biopharmaceuticals
Figure Manufacturing Process Analysis of Biopharmaceuticals
Figure Biopharmaceuticals Industrial Chain Analysis
Table Raw Materials Sources of Biopharmaceuticals Major Manufacturers in 2016
Table Major Buyers of Biopharmaceuticals
Table Distributors/Traders List
Figure EMEA Biopharmaceuticals Sales (Million MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Biopharmaceuticals Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biopharmaceuticals Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Biopharmaceuticals Sales (Million MT) Forecast by Region (2017-2022)
Figure EMEA Biopharmaceuticals Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biopharmaceuticals Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biopharmaceuticals Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biopharmaceuticals Sales (Million MT) Forecast by Countries (2017-2022)
Figure Europe Biopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biopharmaceuticals Sales (Million MT) Forecast by Countries (2017-2022)
Figure Middle East Biopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biopharmaceuticals Sales (Million MT) Forecast by Countries (2017-2022)
Figure Africa Biopharmaceuticals Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biopharmaceuticals Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biopharmaceuticals Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biopharmaceuticals Sales (Million MT) Forecast by Type (2017-2022)
Figure EMEA Biopharmaceuticals Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biopharmaceuticals Sales (Million MT) Forecast by Application (2017-2022)
Figure EMEA Biopharmaceuticals Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top